R&amp,D outsourcing involves pharmaceutical companies subcontracting parts of their R&amp,D efforts to third-party service providers. Small or mid-sized pharmaceutical or biotech houses may use ...

Markus Gershater looks at how automation and artificial intelligence (AI) can transform pharma R&D. Due to increasing complexity in R&D, pharma teams are under pressure to drive down costs and ...

Ramesh and Rajeev Juneja of Mankind Pharma fought popular perceptions and made large acquisitions, focussed on specialty ...

French immunotherapy company OSE Immunotherapeutics has appointed Dr Sonya Montgomery as chief development officer. She will ...

Pharmaceutical and hospital sector executives are requesting higher public healthcare spending, R&D incentives, and tax ...

However, fast-selling GLP-1 medications are also bringing more R&D energy back to the small molecule arena with wider patient pools. Amid this backdrop, here are the forces shaping pharma’s ...

as will aligning R&D, medical affairs, and commercial functions to ensure seamless execution across the value chain. In addition, pharmaceutical companies should focus on elevating business acumen ...

Almirall, a global pharmaceutical company dedicated to medical dermatology, is participating in the 2025 JPMorgan HealthCare ...

10 January 2025 The US Food and Drug Administration approved 50 novel drugs in 2024, continuing to outpace its global regulatory peers.

To identify this year’s Drugs to Watch 2025 list, Clarivate drew from expertise from over 160 Clarivate analysts covering ...